NLRP3 and Hepatic fibrosis: Research indicates that the activation of NLRP3 inflammasome in HSCs can increase the number of α-SMA-positive cells (25), while positive α-SMA expression is the key marker of HSC activation, which is closely related to liver fibrosis progression (26).